Acadia Pharmaceuticals

Pharmaceutical company, which developed Nuplazid, based in San Diego, California.
Organization business Q4671580
Press Enter · cited answer in seconds

Financials

Self-reported XBRL data from 17 annual filings
Revenue
$1.07B
▲ 11.9% YoY FY2025
Net Income
$391.00M
▲ 72.7% YoY FY2025
Assets
$1.56B
▲ 31.7% YoY FY2025
EPS (diluted)
$2.30
▲ 69.1% YoY FY2025
$0.00$294.66M$589.33M$883.99M$1.18B FY2009: $6.40M · NI -$45.15M (-705.5% margin)FY2010: $42.13M · NI $15.14M (35.9% margin)FY2011: $2.07M · NI -$22.77M (-1101.4% margin)FY2012: $4.91M · NI -$20.85M (-424.9% margin)FY2013: $1.15M · NI -$37.95M (-3314.2% margin)FY2014: $120.0K · NI -$92.47M (-77062.5% margin)FY2015: $61.0K · NI -$164.44M (-269578.7% margin)FY2016: $17.33M · NI -$271.39M (-1565.9% margin)FY2017: $124.90M · NI -$289.40M (-231.7% margin)FY2018: $223.81M · NI -$245.19M (-109.6% margin)FY2019: $339.08M · NI -$235.26M (-69.4% margin)FY2020: $441.75M · NI -$281.58M (-63.7% margin)FY2021: $484.14M · NI -$167.87M (-34.7% margin)FY2022: $517.24M · NI -$215.97M (-41.8% margin)FY2023: $726.44M · NI -$61.29M (-8.4% margin)FY2024: $957.80M · NI $226.45M (23.6% margin)FY2025: $1.07B · NI $391.00M (36.5% margin) '09'11'13'15'17'19'21'23'25
■ Revenue ■ Net Income
Source: SEC EDGAR · latest 10-K filed 2025-12-31 · accession 0001193125-26-072519

Summary

Acadia Pharmaceuticals is a business[1]. It ranks in the top 4% of business entities by monthly Wikipedia readership (347 views/month).[2]

Key Facts

  • Country: United States[3]
  • Instance of: public company[4]
  • Headquarters location: San Diego[5]
  • Stock exchange: Nasdaq[6]
  • Industry: pharmaceutical industry[7]
  • Inception: 1993[8]
  • Official website: http://www.acadia-pharm.com/[9]
  • Product or material produced: pimavanserin[10]
  • Legal form: 8888[11]
  • P14750: 51EB-3A81-15E2-DB44-AC9C[12]

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Acadia Pharmaceuticals. Retrieved October 25, 2026, from https://4ort.xyz/entity/acadia-pharmaceuticals
MLA “Acadia Pharmaceuticals.” 4ort.xyz Knowledge Graph, 4ort.xyz, 25 Oct. 2026, https://4ort.xyz/entity/acadia-pharmaceuticals.
BibTeX @misc{4ortxyz_acadia-pharmaceuticals_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Acadia Pharmaceuticals}}, year = {2026}, url = {https://4ort.xyz/entity/acadia-pharmaceuticals}, note = {Accessed: 2026-10-25}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Acadia Pharmaceuticals — https://4ort.xyz/entity/acadia-pharmaceuticals (retrieved 2026-10-25)

Canonical URL: https://4ort.xyz/entity/acadia-pharmaceuticals · Last refreshed:

Edit History

Rolling log of changes to this entity's Wikidata record. Values shown reflect the current state of each edited property — follow the history link to see the precise diff for any edit.

  1. 9w ago · Trivialist · 2026-08-22 view diff on Wikidata ↗
    Isni → —
    Openalex id → —
    Twitter → —
    Ringgold id → —
    + 42 other properties edited (see Wikidata diff for full list)
    "/* wbcreateclaim-create:1| */ P14750: 51EB-3A81-15E2-DB44-AC9C, [[:toollabs:quickstatements/#/batch/269299|batch #269299]]"
Live feed via Wikidata EventStreams. New edits appear within minutes of being made on Wikidata.